Landon Long Chan

10PUBLICATIONS
24CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 26, 2026
Systemic Therapy for Advanced Hepatocellular Carcinoma in 2026: Current Standard-of-Care and Emerging Therapeutic Strategies.

Landon L Chan, Kallista O K Chan, Stephen L Chan

|Dec 24, 2025
Clinical Implications of Upregulated RSAD2 Gene Expression in Hepatocellular Carcinoma.

Leung Li, Nelson L S Tang, Stephen L Chan

|Oct 30, 2025
Clinical management of liver cancer patients with immune checkpoint inhibitors treatment.

Johnny C W Yau, Landon L Chan, Stephen L Chan

|Sep 06, 2025
Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer.

Dorothy Cheuk-Yan Yiu, Jimmy Che-To Lai, Landon Long Chan

|Mar 27, 2025
Future perspectives on immunotherapy for hepatocellular carcinoma.

Landon L Chan, Stephen L Chan

|Dec 09, 2024
Next-generation immunotherapy: igniting new hope for lung cancer.

Molly S C Li, Andrew L S Chan, Kevin K S Mok

Pageof 2

Frequent Collaborators

5 joint publications

Stephen Lam Chan

1 joint publications

Molly S C Li

1 joint publications

Kevin K S Mok

1 joint publications

Johnny C W Yau